Malignant schwannoma following treatment for Hodgkin's disease
โ Scribed by P.M. Fisher; D.J. Dodwell; L.R. Bridges; S.C. Cartwright; J. Stone
- Book ID
- 108473220
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 139 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1433-2981
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Considerable progress has been made in the treatment of Hodgkin's disease and the other lymphomas during the past 15 years. The present paper summarizes, in part, studies which our department has conducted or in which we have participated during this period. Studies of chlorambucil, pre
The risk of second malignant neoplasm (SMN) was evaluated in 979 children with Hodgkin's disease. This cohort was diagnosed between 1955 and 1979 at one of the institutions of the Late Effects Study Group. Solid tumors, non-lymphocytic leukemia, and non-Hodgkin's lymphoma (NHL) developed in 18, 17,
Although it is well known that the risk of non-Hodgkin's lymphoma (NHL) is elevated significantly after treatment for Hodgkin's disease,' an increased risk of Hodgkin's disease following NHL has not been noted in several large cancer registry Although descriptions of Hodgkin's disease following NHL